Results 281 to 290 of about 65,572 (317)

Management of acute type B aortic dissections

Expert Review of Cardiovascular Therapy, 2016
For the last several decades, initial management of Stanford type B aortic dissections (DeBakey IIIa or IIIb) has involved medical therapy aimed at reducing blood pressure and impulse stress (Dp/dT). This concept has been indoctrinated into the medical field but is now being challenged with advancements in endovascular therapies and devices.
Vikalp, Jain, Mark A, Farber, Raghuveer, Vallabhaneni   +2 more
openaire   +2 more sources

Thoracic Endovascular Aortic Repair for Type B Aortic Dissection

Annals of Vascular Surgery, 2010
Thoracic endovascular aortic repair (TEVAR) has emerged as an acceptable off-label treatment modality for aortic dissection. We report our experience in endovascular treatment of this disease with an emphasis on defining the patterns of morbidity.We retrospectively reviewed all (n = 90) patients with thoracic aortic disease who received a TEVAR between
Houssam K, Younes, Patricia W, Harris, Jean, Bismuth, Kristofer, Charlton-Ouw, Eric K, Peden, Alan B, Lumsden, Mark G, Davies   +6 more
openaire   +2 more sources

Type B Aortic Dissections

Cardiology Clinics, 2017
Daniel B. Alfson, Sung W. Ham
openaire   +1 more source

STABILISE for acute type B aortic dissection

International Angiology
Stent-assisted, balloon-induced intimal disruption and relamination of aortic dissection (STABILISE) is an extended downstream endovascular management technique for acute type B aortic dissection (TBAD), that aimed to achieve complete aortic remodeling.
Tatiana, Cotão, Joel, Sousa, Armando, Mansilha   +2 more
openaire   +2 more sources

Type B aortic dissection

Journal of Cardiovascular Medicine, 2018
Francesca, Terzi, Silvia, Gianstefani, Rossella, Fattori   +2 more
openaire   +2 more sources

Treatment of uncomplicated type B aortic dissection

General Thoracic and Cardiovascular Surgery, 2016
Hospital mortality after the replacement of chronic type B aortic dissection is around 8-10% and adverse outcomes include paraplegia and stroke. However, the level of evidence for indication of thoracic endovascular aortic repair (TEVAR) for type B chronic aortic dissection is Class IIa.
openaire   +2 more sources

Type B Aortic Dissection

2022
openaire   +1 more source

Type A Aortic Dissection

2010
Philippe Demers, D. Craig Miller
openaire   +1 more source

Acute type B aortic dissection

Italian Journal of Vascular and Endovascular Surgery, 2018
Hosn, Maen A., Pascarella, Luigi
openaire   +1 more source

Iris Flocculi and Type B Aortic Dissection

Ophthalmology, 2017
Overwater, Eline, Houweling, Arjan C.
openaire   +3 more sources